Daiichi Sankyo Korea, Daewoong to co-market Sevikar HCT

Daiichi Sankyo Korea and Daewoong Pharma on Monday announced that the two companies have signed an agreement to co-market Sevikar HCT tablets here.

Sevikar HCT, which contains three active ingredients, amlodipine, olmesartan and hydrochlorothiazide, is the first three-in-one pill to treat hypertension. All these medicines are used to lower high blood pressure. They all work in different ways...